CAS.NO: 844439-96-9
Insulin Degludec, diabetes API, is an ultra-long-acting insulin analogue. Previous studies have shown that it has an ultra-long-term hypoglycemic effect and can reduce the risk of hypoglycemia.
Insulin Degludec Injection Specifications
Product Name | Insulin Degludec |
Packing Specification | 10g/100g/500g |
Appearances | White or off-white powder |
Activity: NLT 10Unit/mg | NLT 10Unit/mg |
Content: 95.0%~105.0% | 95.0%~105.0% |
Bacterial Endotoxin | Less than 10 EU/mg |
Residual HCP | NMT 10ng/mg |
Residual Exogenous DNA | NMT 10ng/dose |
Macromolecular Potein | NMT 0.4% |
HPLC Purity | ＞99.0% |
Storage Conditions | -15℃ below, protected from light, sealed |
Insulin Degludec Recommended Method
Insulin Degludec easy dissolved in acidic (pH<2.5), neutral and alkaline conditions, and can be dissolved and clarified above pH7.0.
Insulin Degludec Transport and Storage Stability
Transportation stability: It is transported in an ice pack to keep it active.
Storage stability: The product can be stored for at least 24 months at -15°C below.
Notice and Disclaimer
Pollution should be avoided during operation.
The product should not be used for diagnosis or treatment of animals or humans.
Now the price of insulin degludec cost is reasonable, if you have needs, please contact us.
If you want to know more details of insulin degludec uses and insulin degludec duration of action, please visit our website.
As one of the leading biopharmaceutical manufacturing companies, Gene Biocon is committed to offering biologic pharmacy products through development and innovation.
